Position in GH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,317,963
+$886,506 QoQ
Shares Held
15,450
-0.3% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#250
of 594 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Numerai GP LLC holds $8,897,038 across 7 Diagnostics & Research names. GH ranks #1 (26.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
This page
|
15,450 | $2,317,963 | |
| 2 | DHR |
Danaher Corp /De/
|
8,999 | $1,714,129 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
2,868 | $1,518,864 | |
| 4 | DGX |
Quest Diagnostics Inc
|
6,196 | $1,313,242 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
959 | $1,225,132 | |
| 6 | ICLR |
Icon PLC
|
3,229 | $560,909 | |
| 7 | CSTL |
Castle Biosciences Inc
|
10,348 | $246,799 |
All Filings in GH
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,317,963 | 15,450 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,431,457 | 15,497 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,417,294 | 13,876 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $328,403 | 7,709 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||